Brief: Biohit H2 operating loss flat at EUR 1.3 mln
20/02/2017 07:30
Feb 20 (Reuters) - Biohit Oyj BIOBV.HE :
* H2 net sales 4.4 million euros ($4.67 million) versus 2.5 million euros year ago
* H2 operating loss 1.3 million euros versus loss 1.4 million euros year ago
* Board of directors proposes to annual general meeting that no dividend be paid for
financial year
* China's operations are in Biohit's focus in 2017
* Expects to complete reduction of joint venture share capital during Q1 of 2017
* Estimates its non-comparable operating result to turn clearly positive for 2017
* Net sales growth is expected in 2017
* Company does not assess when comparable result will turn to positive
Source text for Eikon: ID:nHSU6M9t
Further company coverage: BIOBV.HE
($1 = 0.9416 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))